JP2015533174A - ピロカルピンの医薬製剤 - Google Patents

ピロカルピンの医薬製剤 Download PDF

Info

Publication number
JP2015533174A
JP2015533174A JP2015536950A JP2015536950A JP2015533174A JP 2015533174 A JP2015533174 A JP 2015533174A JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015533174 A JP2015533174 A JP 2015533174A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
weight
core
composition according
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015536950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533174A5 (enExample
Inventor
メディ パボルジ
メディ パボルジ
ロバート ヴィー． トゥオヒー
ロバート ヴィー． トゥオヒー
ステファン ピー． レヴィン
ステファン ピー． レヴィン
ダナ イー． モーゼソン
ダナ イー． モーゼソン
ニコラス ディー． カークランド
ニコラス ディー． カークランド
Original Assignee
セラヴィダ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セラヴィダ，インコーポレイテッド filed Critical セラヴィダ，インコーポレイテッド
Publication of JP2015533174A publication Critical patent/JP2015533174A/ja
Publication of JP2015533174A5 publication Critical patent/JP2015533174A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2015536950A 2012-10-11 2013-10-11 ピロカルピンの医薬製剤 Pending JP2015533174A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712784P 2012-10-11 2012-10-11
US61/712,784 2012-10-11
PCT/US2013/064596 WO2014059309A1 (en) 2012-10-11 2013-10-11 Pharmaceutical formulations of pilocarpine

Publications (2)

Publication Number Publication Date
JP2015533174A true JP2015533174A (ja) 2015-11-19
JP2015533174A5 JP2015533174A5 (enExample) 2016-12-01

Family

ID=50475520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015536950A Pending JP2015533174A (ja) 2012-10-11 2013-10-11 ピロカルピンの医薬製剤

Country Status (5)

Country Link
US (1) US20140105976A1 (enExample)
JP (1) JP2015533174A (enExample)
KR (1) KR20150068460A (enExample)
CA (1) CA2885979A1 (enExample)
WO (1) WO2014059309A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
BR112013028755A2 (pt) 2011-05-10 2017-01-31 Theravida Inc combinações de solifenacina e estimulantes salivares para o tratamento de bexiga hiperativa
WO2017127073A1 (en) 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis
US20210100275A1 (en) * 2018-02-19 2021-04-08 Sensient Colors Llc Compositions for coating edible substrates and methods of making and using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005521706A (ja) * 2002-03-29 2005-07-21 アルザ・コーポレーシヨン 体積効果的放出制御製剤
JP2008516893A (ja) * 2004-08-27 2008-05-22 スフェリックス，インク． 多層錠剤および生体接着性剤形
WO2011123836A2 (en) * 2010-04-01 2011-10-06 Theravida, Inc. Pharmaceutical formulations for the treatment of overactive bladder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
EP1755557A4 (en) * 2004-05-19 2007-08-29 Glatt Air Tech Inc GRANULES CONTAINING MICROGRANULES AND PROCESS FOR THE PREPARATION THEREOF
WO2006031420A2 (en) * 2004-08-27 2006-03-23 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005521706A (ja) * 2002-03-29 2005-07-21 アルザ・コーポレーシヨン 体積効果的放出制御製剤
JP2008516893A (ja) * 2004-08-27 2008-05-22 スフェリックス，インク． 多層錠剤および生体接着性剤形
WO2011123836A2 (en) * 2010-04-01 2011-10-06 Theravida, Inc. Pharmaceutical formulations for the treatment of overactive bladder

Also Published As

Publication number Publication date
CA2885979A1 (en) 2014-04-17
KR20150068460A (ko) 2015-06-19
WO2014059309A1 (en) 2014-04-17
US20140105976A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
JP4463875B2 (ja) 医薬組成物
JP6215239B2 (ja) ダビガトランエテキシラートの経口医薬組成物
CN104136004B (zh) 多西拉敏和吡哆醇和/或其代谢物或盐的制剂
JP2020535158A (ja) ニラパリブ処方物
TW201102064A (en) Pharmaceutical composition having improved dissolution property
JP2014533656A5 (enExample)
JP2015500853A (ja) 即時放出マルチユニットペレットシステム
KR101923403B1 (ko) 리마프로스트 또는 리마프로스트 알파엑스를 함유한 경구용 서방성 제제 조성물
CN106794149A (zh) 含ω‑3脂肪酸酯和他汀类的口服给药复合制剂
EP2740471A1 (en) Oral pharmaceutical composition comprising dabigatran etexilate
JP2015533174A (ja) ピロカルピンの医薬製剤
EP1154762A1 (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
US8999384B2 (en) Immediate release compositions of acid labile drugs
JP2012140335A (ja) 不快味マスキング粒子及びこれを含有する経口製剤
JP2019532960A (ja) エソメプラゾール含有複合カプセル剤及びその製造方法
JP6866136B2 (ja) デュロキセチン塩酸塩を含む口腔内崩壊錠
CN104768552A (zh) 含有盐酸氢吗啡酮的口服持续释放药物组合物
WO2003075919A1 (fr) Comprime contenant du chlorhydrate de pilsicainide (voie seche)
TW202504582A (zh) 普達芬辛之延長釋放調配物
JP6972674B2 (ja) 経口医薬製剤
KR20250110202A (ko) 변형-방출 실로도신 조성물 및 남성 피임 방법에서 이의 용도
JP2022062674A (ja) 懸濁性顆粒及びそれを用いた懸濁用顆粒製剤
JPH04230626A (ja) 改良されたゲムフィブロジル組成物
CN105326813A (zh) 帕罗西汀缓释组合物及其制备方法
JP2015091769A (ja) アリピプラゾール含有口腔内崩壊錠剤及びその製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161006

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170822

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181023